>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>Nimustine hydrochloride

Nimustine hydrochloride (Synonyms: ACNU, NSC-D 245382)

Catalog No.GC36743

Nimustine hydrochloride(ACNU)는 교모세포종에 대한 화학요법에 일반적으로 사용되는 DNA 복제 차단 병변 및 DNA 이중 가닥 파손을 유도하고 DNA 합성을 억제하는 DNA 가교 및 DNA 알킬화제입니다.

Products are for research use only. Not for human use. We do not sell to patients.

Nimustine hydrochloride Chemical Structure

Cas No.: 55661-38-6

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$52.00
재고 있음
5mg
US$46.00
재고 있음
10mg
US$74.00
재고 있음
50mg
US$232.00
재고 있음
100mg
US$417.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Nimustine hydrochloride (ACNU) is a DNA cross-linking and DNA alkylating agent, which induces DNA replication blocking lesions and DNA double-strand breaks and inhibits DNA synthesis, commonly used in chemotherapy for glioblastomas[1][2][3].

[1]. Tomicic MT, et al. Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/c-Jun-mediated induction of the BH3-only protein BIM. Oncotarget. 2015 Oct 20;6(32):33755-68. [2]. Kondo N, et al. FANCD1/BRCA2 plays predominant role in the repair of DNA damage induced by ACNU or TMZ. PLoS One. 2011 May 9;6(5):e19659. [3]. Mineura K, et al. DNA lability induced by nimustine and ramustine in rat glioma cells. J Neurol Neurosurg Psychiatry. 1988 Nov;51(11):1391-4.

리뷰

Review for Nimustine hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Nimustine hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.